Inactive Instrument

Company PERRIGO TEL AVIV STOCK EXCHANGE

Equities

Pharmaceuticals

End-of-day quote TEL AVIV STOCK EXCHANGE
- ILa - Intraday chart for PERRIGO

Business Summary

Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.

Sales per Business

USD in Million2022Weight2023Weight Delta
Consumer Self-Care Americas
63.6 %
2,926 65.7 % 2,962 63.6 % +1.24%
Consumer Self-Care International
36.4 %
1,526 34.3 % 1,693 36.4 % +10.99%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
62.7 %
2,870 64.5 % 2,917 62.7 % +1.63%
Europe
34.0 %
1,445 32.5 % 1,582 34.0 % +9.46%
All Other Countries
2.5 %
107 2.4 % 116 2.5 % +8.39%
Ireland
0.9 %
29 0.7 % 41 0.9 % +39.25%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 23-06-29
Director of Finance/CFO 49 22-05-15
Chief Tech/Sci/R&D Officer - 14-12-31
Chief Tech/Sci/R&D Officer 54 13-12-31
Chief Operating Officer 58 02-12-31
Chief Tech/Sci/R&D Officer 66 06-09-30
Investor Relations Contact - -
Corporate Officer/Principal 44 -
Corporate Officer/Principal 55 23-09-10
Human Resources Officer 55 13-04-30

Members of the board

Members of the board TitleAgeSince
Chairman 55 20-12-14
Director/Board Member 68 17-02-05
Director/Board Member 67 17-02-05
Director/Board Member 73 14-10-31
Director/Board Member 59 16-11-06
Director/Board Member 61 17-05-01
Director/Board Member 56 20-07-28
Chief Executive Officer 55 23-06-29
Director/Board Member 54 10-31
Director/Board Member 60 22-07-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 136,320,433 135,858,122 ( 99.66 %) 0 99.66 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
10.94 %
14,916,915 10.94 % 411 M ILa
BlackRock Advisors LLC
9.115 %
12,425,542 9.115 % 342 M ILa
6,788,873 4.980 % 187 M ILa
DFA Australia Ltd.
4.892 %
6,669,239 4.892 % 184 M ILa
DePrince, Race & Zollo, Inc.
2.561 %
3,490,792 2.561 % 96 M ILa
Cooke & Bieler LP
2.546 %
3,471,251 2.546 % 96 M ILa
Davenport & Co. LLC
2.530 %
3,449,352 2.530 % 95 M ILa
Thompson, Siegel & Walmsley LLC
2.527 %
3,444,729 2.527 % 95 M ILa
Wolf Hill Capital Management LP
2.243 %
3,057,798 2.243 % 84 M ILa
Slate Path Capital LP
2.087 %
2,845,000 2.087 % 78 M ILa

Company contact information

Perrigo Co. Plc

The Sharp Building Hogan Place

2, Dublin

+353 1 709 4000

http://www.perrigo.com
address PERRIGO

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Medical Distributors
Pharmaceuticals: Major
Financial Conglomerates
Medical Distributors
Elan Finance Plc
Finance/Rental/Leasing
Financial Conglomerates
Pharmaceuticals: Major
Finance/Rental/Leasing